Medicines, Devices & Diagnostic Tools

Own healthcare product suppliers across medicines, medical devices and diagnostic tools rather than another drug-only basket. Lilly's recent share-price strength provides a timely company-specific signal, while device and instrument manufacturers broaden the sources of demand beyond pharmaceutical pipelines. Procedure activity, laboratory spending and drug adoption offer distinct growth drivers, although reimbursement pressure and product execution remain risks. Catalysts: - 2026-10-20 LLY: Eli Lilly shares rise 3.6% as its GLP-1 franchise stays in focus (https://www.marketbeat.com/instant-alerts/price-eli-lilly-and-company-nyse-lly-shares-climb-36-still-a-buy-2026-10-20/) Launch basket (equal weight): MDT, JNJ, TMO, LLY, ABBV, ABT, BSX, SYK, ISRG, GEHC Rules: 1. No inverse, leveraged or volatility ETFs. 2. Only names tradable at the enrolled brokers (Moomoo): no OTC listings, no dead tickers, nothing on the refused list.